CD3 Antikörper
-
- Target Alle CD3 Antikörper anzeigen
- CD3
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD3 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Functional Studies (Func)
- Spezifität
- Recognises a 20-32 kDa protein
- Aufreinigung
- Ion exchange chromatography
- Sterilität
- 0.22 μm filtered
- Immunogen
- PHA activated T cells,Myeloma X63/AG.8653 x Balb/c spleen cells
- Klon
- B-B11
- Isotyp
- IgG1 kappa
- Biological Activity Comment
- Induces T lymphocyte stimulation and proliferation
- Top Product
- Discover our top product CD3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
Characterization of monoclonal antibodies directed against trail or trail receptors." in: Cellular immunology, Vol. 236, Issue 1-2, pp. 86-91, (2005) (PubMed).
: "Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance." in: Journal of virology, Vol. 78, Issue 13, pp. 7079-88, (2004) (PubMed).
: "Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejection." in: Transplantation, Vol. 62, Issue 10, pp. 1502-6, (1997) (PubMed).
: "
-
Characterization of monoclonal antibodies directed against trail or trail receptors." in: Cellular immunology, Vol. 236, Issue 1-2, pp. 86-91, (2005) (PubMed).
-
- Target
- CD3
- Andere Bezeichnung
- CD3 (CD3 Produkte)
- Molekulargewicht
- 20-32 kDa
- Pathways
- T-Zell Rezeptor Signalweg, Ubiquitin Proteasome Pathway
-